Reply to Smith et al., Salton et al., Smit et al., and to Kraft and Despotovic [0.03%]
回复Smith等人、Salton等人、Smit等人以及Kraft和Despotovic的意见
Barbara E Jones,Julio A Ramirez
Barbara E Jones
ComPLEX Controversy: Management of alveolar hemorrhage in ANCA-associated vasculitis [0.03%]
复杂争议：抗中性粒细胞胞浆抗体相关性血管炎的肺泡出血处理
Lynn A Fussner,Guy N Brock,Rona M Smith
Lynn A Fussner
Reply to the Infectious Disease Society of America (IDSA) Position Statement [0.03%]
致美国传染病学会(IDSA)意见书的回复
Barbara E Jones,Julio A Ramirez
Barbara E Jones
Identification of a conserved sequence of disease progression in Idiopathic Pulmonary Fibrosis [0.03%]
特发性肺纤维化疾病进展中保守的序列识别
Xiang Huang,Pingsheng Wu,Adam R Guttentag et al.
Xiang Huang et al.
Rationale: Idiopathic pulmonary fibrosis (IPF) begins years before symptoms appear, but the natural history is incompletely understood. Objectives: ...
Nerandomilast in idiopathic pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-IPF trial [0.03%]
尼达尼布在特发性肺纤维化中的作用：FIBRONEER-IPF试验的全部随访数据
Justin M Oldham,Arata Azuma,Michael Kreuter et al.
Justin M Oldham et al.
Rationale: In the randomized placebo-controlled FIBRONEER-IPF trial in patients with idiopathic pulmonary fibrosis, both nerandomilast 9 mg bid and 18 mg bid met the primary endpoint of reducing decline in forced vital ca...
Pulmonary Vascular Growth in Bronchopulmonary Dysplasia Using Magnetic Resonance Imaging [0.03%]
磁共振成像用于支气管肺发育不良的肺血管增生状况研究
James A Rowe,Paul J Critser,Nara S Higano et al.
James A Rowe et al.
Sujeet Rajan Dr,Asmita A Mehta Dr,Bhavin Jankharia Dr
Sujeet Rajan Dr
Lower Airway Dysbiosis in NTM+ Bronchiectasis is Associated with NET-Predominant Severe Phenotypes [0.03%]
NTM阳性支气管扩张患者的下呼吸道菌群失调与NET为主型的重症表型相关
Shivani Singh,Fares Darawshy,Kirby Erlandson et al.
Shivani Singh et al.
Rationale: The discoveries of neutrophilic inflammation and Pseudomonas-dominant pulmonary dysbiosis have helped pave the way for host-directed therapy in bronchiectasis. Substantial knowledge gaps still remain about the ...
Infectious Diseases Society of America (IDSA) Position Statement: Why IDSA Did Not Endorse the Community-Acquired Pneumonia Guidelines 2025 Update [0.03%]
美国感染病学会(IDSA)立场声明：美国感染病学会未支持“社区获得性肺炎指南2025更新”版本的原因
Michael Klompas,Majdi Al-Hasan,Mayar Al Mohajer et al.
Michael Klompas et al.